The global animal model market size is expected to reach USD 4.01 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 8.6% over the forecast period. Factors, such as the growing demand for precision medicine coupled with the rising implication of animal models owing to physiological similarities between humans and animals are driving the global market growth. In addition, advancements in animal-based models and rising implications of genetic engineering are propelling market expansion. The rising burden of life-threatening diseases like cancer, neurological disorders, cardiovascular disorders, and immunological disorders created an exponential demand for animal models.
These models help researchers in evaluating drug candidates, study disease progression, and allow testing therapeutic remedies prior they testing in human beings. Thus, the rising burden of chronic conditions has fueled the demand for animal-based models for research purposes. In addition, increasing efforts by pharmaceutical and biotechnology companies to develop novel therapeutics along with an increasing number of preclinical trials are projected to fuel the demand for various models like mice, guinea pigs, and others. Moreover, the introduction of CRISPR technology has revolutionized the field of genetics and biotechnology, while also allowing to create models with specific gene modifications to understand human diseases and develop newer treatments.
CRISPR technology offers a faster and more precise way to create animal models with specific genetic modifications. Using CRISPR, researchers can easily introduce, remove, or modify specific genes in the genome of an animal, allowing them to create animal models with precise genetic changes that are relevant to human diseases. For instance, in December 2022, Alberto Sols Biomedical Research Institute & Complutense University of Madrid utilized the CRISPR gene editing technique to incorporate a mutation into a mouse. The mutation carried the MCT8 protein, which is responsible for transporting thyroid hormones to the interior of human cells. The avatar mouse model will allow the researchers to curate a targeted therapy for Allan-Herndon-Dudley syndrome, a rare condition revealing an MCT8 mutation.
Request a free sample copy or view report summary: Animal Model Market Report
The mice segment dominated the market in 2022 with a revenue share of 52.7%. Factors, such as increasing investments and technological advancement in mouse model technology, are anticipated to drive the segment growth over the forecast years
The cancer application segment held the largest revenue share in 2022 and is expected to register the fastest growth rate over the forecast period
The pharmaceutical & biotechnology companies end-use segment dominated the market with a revenue share of 39.1% in 2022. Increasing efforts by companies to develop novel treatment regimens are projected to drive segment growth over the forecast period
North America dominated the global industry in 2022 with a revenue share of 48.95% owing to the presence of key companies and various strategic initiatives undertaken by them
Grand View Research has segmented the global animal model market based on animal type, application, end-use, and region:
Animal Model Animal Type Scope Outlook (Revenue, USD Million, 2018 - 2030)
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
Animal Model Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
Cancer
Immunological Disease
Infectious Disease
Others
Animal Model End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
Animal Model Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Norway
Sweden
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Animal Model Market
Charles River Laboratories
The Jackson Laboratory
genOway
Taconic Biosciences, Inc.
Janvier Labs
Harbour BioMed
Crown Bioscience
Inotiv
BIOCYTOGEN
BioSpherix, Ltd.
"The quality of research they have done for us has been excellent..."